Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Probiodrug Appoints Business & Strategy EVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Probiodrug Appoints Business & Strategy EVP

Dr. Michael Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development

By: Betsy Louda

, Contract Pharma

Probiodrug AG announced that Dr. Michael Schaeffer has been appointed to the position of executive vice president of Business and Strategy, effective August 2018. 

 
Dr. Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development, scientific project and alliance management to Probiodrug.

Chief executive officer of Probiodrug, Dr. Ulrich Dauer, said, “We are very pleased Michael has joined our team. His entrepreneurial skill sets and extensive experience in strategic business development for neurology projects across all stages of drug development will be invaluable in defining Probiodrug’s business strategies. Additionally, he brings significant experience in advancing innovations in R&D alliance and CRO partnership management on a global scale. Together we look forward to tackling the next developmental stages of our lead candidate PQ912 as we prepare for our upcoming global Phase 2b studies.”

Prior to joining Probiodrug, Dr. Schaeffer was the founder and managing director of biotech companies, CRELUX GmbH and SiREEN AG.

“I was looking for an exciting business development role at a company that develops innovative drugs based on outstanding science and for indications with an extremely high medical need. Probiodrug exactly matches these requirements – I look forward to making a significant contribution as we are advancing our drug discovery programs” Dr. Michael Schaeffer said.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters